Understanding hERG inhibition with QSAR models based on a one-dimensional molecular representation

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Computational Toxicology

Background:

• Blockage of the human ether-a-go-go related gene (hERG) potassium channel is a primary cause of drug-induced cardiotoxicity.
• Extensive in vitro and in vivo assays are employed to identify compounds with hERG inhibitory activity.
• Quantitative structure activity relationship (QSAR) models are crucial for early-stage elimination of compounds likely to exhibit hERG inhibition.

Purpose of the Study:

• To develop and present a novel QSAR technique utilizing a one-dimensional representation for predicting hERG inhibition.
• To create a robust mathematical framework for integrating diverse experimental data, including quantitative (e.g., IC50) and qualitative (e.g., inactive) measurements, into QSAR models.

Main Methods:

• Development of a new QSAR model based on a one-dimensional representation.
• Implementation of a mathematical scheme to incorporate both quantitative (IC50 values) and qualitative (activity/inactivity) data.
• Validation of the model's performance against the quality of the available dataset.

Main Results:

• The developed QSAR model demonstrates predictive performance close to the data quality limitations.
• The novel mathematical scheme successfully integrates quantitative and qualitative experimental data without information loss.
• The model effectively predicts hERG inhibition, aiding in the early identification of potential cardiotoxic compounds.

Conclusions:

• The new QSAR approach offers a valuable tool for predicting hERG channel inhibition.
• Simultaneous incorporation of quantitative and qualitative data enhances the robustness and utility of QSAR models.
• This method contributes to the early safety assessment of drug candidates, reducing the risk of cardiotoxicity.